Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/13/23 → 10/13/23 |
Funding
- Janssen Research and Development LLC: $11,094.00
Start Up Costs Only: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2a Study for Safety and Immunogenicity Evaluations of Various RSV.preF-based Vaccine Formulations in Adults Aged 60 Years and Older
- Greenberg, Richard (PI)
- Caudill, Timothy (CoI)
- Simmons, Christopher (CoI)